Clinical Presentation of Connective Tissue Disease Patients with and without Interstitial Lung Disease: A Retrospective Study.

Antisynthetase syndrome Idiopathic inflammatory myopathy Interstitial lung disease Rheumatoid arthritis Sjӧgren’s syndrome Systemic sclerosis

Journal

Respiration; international review of thoracic diseases
ISSN: 1423-0356
Titre abrégé: Respiration
Pays: Switzerland
ID NLM: 0137356

Informations de publication

Date de publication:
2023
Historique:
received: 09 02 2023
accepted: 11 04 2023
medline: 22 6 2023
pubmed: 26 5 2023
entrez: 26 5 2023
Statut: ppublish

Résumé

Connective tissue diseases (CTDs) are responsible for about 20% of interstitial lung disease (ILD) cases, but their diagnosis in a pulmonary unit (PU) is not always straightforward due to a heterogeneous clinical picture. The aim of this study was to evaluate the clinical presentation of rheumatoid arthritis (RA) and CTD-ILD cases diagnosed in PU, compared to RA and CTD patients diagnosed in a rheumatologic unit (RU). Patients with RA, systemic sclerosis (SSc), primary Sjӧgren's syndrome (pSS), and idiopathic inflammatory myopathy were retrospectively enrolled from an RU and a PU designated to manage ILD during a period from January 2017 to October 2022. The classification of CTD-PU was carried out in a multidisciplinary setting, including the same rheumatologists that diagnosed CTD in the RU. ILD-CTD-PU patients were prevalently male and older. Progression from undifferentiated CTD to a specific condition was more common in ILD-CTD-PU, and those patients generally obtained a lower score on specific classification criteria. RA-PU patients resembled polymyalgia rheumatica in 47.6% of cases, also showing a greater proportion of typical joint deformities (p = 0.02). SSc-PU patients showed a usual interstitial pneumonia pattern in 76% of cases and, compared with SSc-RU, were more commonly seronegative (p = 0.03) and generally lacked fingertip lesions (p = 0.02). The majority of the diagnoses of pSS-PU were in patients with previously diagnosed ILD, in which seropositivity and sicca syndrome developed during follow-up. CTD-ILD patients diagnosed in the PU show severe lung involvement and a nuanced autoimmune clinical picture.

Sections du résumé

BACKGROUND
Connective tissue diseases (CTDs) are responsible for about 20% of interstitial lung disease (ILD) cases, but their diagnosis in a pulmonary unit (PU) is not always straightforward due to a heterogeneous clinical picture.
OBJECTIVES
The aim of this study was to evaluate the clinical presentation of rheumatoid arthritis (RA) and CTD-ILD cases diagnosed in PU, compared to RA and CTD patients diagnosed in a rheumatologic unit (RU).
METHODS
Patients with RA, systemic sclerosis (SSc), primary Sjӧgren's syndrome (pSS), and idiopathic inflammatory myopathy were retrospectively enrolled from an RU and a PU designated to manage ILD during a period from January 2017 to October 2022. The classification of CTD-PU was carried out in a multidisciplinary setting, including the same rheumatologists that diagnosed CTD in the RU.
RESULTS
ILD-CTD-PU patients were prevalently male and older. Progression from undifferentiated CTD to a specific condition was more common in ILD-CTD-PU, and those patients generally obtained a lower score on specific classification criteria. RA-PU patients resembled polymyalgia rheumatica in 47.6% of cases, also showing a greater proportion of typical joint deformities (p = 0.02). SSc-PU patients showed a usual interstitial pneumonia pattern in 76% of cases and, compared with SSc-RU, were more commonly seronegative (p = 0.03) and generally lacked fingertip lesions (p = 0.02). The majority of the diagnoses of pSS-PU were in patients with previously diagnosed ILD, in which seropositivity and sicca syndrome developed during follow-up.
CONCLUSIONS
CTD-ILD patients diagnosed in the PU show severe lung involvement and a nuanced autoimmune clinical picture.

Identifiants

pubmed: 37231870
pii: 000530785
doi: 10.1159/000530785
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

405-415

Informations de copyright

© 2023 S. Karger AG, Basel.

Auteurs

Gianluca Sambataro (G)

Regional Referral Centre for Rare Lung Diseases, AOU "Policlinico G. Rodolico-San Marco", University of Catania, Catania, Italy.
Artroreuma srl Rheumatology Outpatient Clinic associated with the National Health System, Mascalucia (CT), Italy.

Alessandro Libra (A)

Regional Referral Centre for Rare Lung Diseases, AOU "Policlinico G. Rodolico-San Marco", University of Catania, Catania, Italy.

Lucia Spicuzza (L)

Regional Referral Centre for Rare Lung Diseases, AOU "Policlinico G. Rodolico-San Marco", University of Catania, Catania, Italy.

Stefano Palmucci (S)

Department of Medical-Surgical Sciences and Advanced Technologies G.F. Ingrassia - Radiology I Unit, University Hospital Policlinico G. Rodolico-San Marco, Catania, Italy.

Paola Conti (P)

Regional Referral Centre for Rare Lung Diseases, AOU "Policlinico G. Rodolico-San Marco", University of Catania, Catania, Italy.

Eugenio Spagnolo (E)

Regional Referral Centre for Rare Lung Diseases, AOU "Policlinico G. Rodolico-San Marco", University of Catania, Catania, Italy.

Michele Colaci (M)

Internal Medicine Unit, Division of Rheumatology, Department of Clinical and Experimental Medicine, Cannizzaro Hospital, University of Catania, Catania, Italy.

Lorenzo Malatino (L)

Internal Medicine Unit, Division of Rheumatology, Department of Clinical and Experimental Medicine, Cannizzaro Hospital, University of Catania, Catania, Italy.

Martina Orlandi (M)

Division of Rheumatology AOUC Careggi, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Domenico Sambataro (D)

Artroreuma srl Rheumatology Outpatient Clinic associated with the National Health System, Mascalucia (CT), Italy.

Carlo Vancheri (C)

Regional Referral Centre for Rare Lung Diseases, AOU "Policlinico G. Rodolico-San Marco", University of Catania, Catania, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH